Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh

from Talking Biotech with Dr. Kevin Folta

In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Dr. Neela Patel and Dr. Diane Hollenbaugh from Bonum Therapeutics about the emerging field of conditionally active biologics. They discuss the challenges of current therapies, the innovative mechanisms behind their drug development, and the potential of immuno-oncology to revolutionize cancer treatment. The conversation also covers the market landscape, the origin story of Bonum, and the future directions for their pipeline, emphasizing the importance of targeted therapies in improving patient outcomes.

Episode metadata supplied by the publisher feed · Published Feb 27, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh

0:00 46:30

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking Biotech with Dr. Kevin Folta?

This episode is 46 minutes long.

When was this Talking Biotech with Dr. Kevin Folta episode published?

This episode was published on February 27, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Talking Biotech with Dr. Kevin Folta episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!